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In conclusion, TS in recipients of TBI is associated with signif-
icantly lower risk of opportunistic infections without any deleteri-
ous effect on hematopoietic recovery in recipients of AD-HSCT.
While these results indicate that TS reduces the infection rate and
potentially improves survival in patients with FA, they also suggests
that TS should be considered for other high risk populations (e.g.
adults) and in those with other non malignant disorders. While it
appears that immune reconstitution is improved based on the
reduced incidence of opportunistic infections, correlative labora-
tory assessments (TREC, CD4 recovery) are currently being per-
formed.
Impact of TS on HSCT Outcomes
Preparative
Therapy
Probability
of
Neutrophil
Engraftment
(95% CI)
Probability
of Survival
at 1 Year
(95% CI)
Total #
Infections
#Bacterial
Infections
#Viral
Infections
#Fungal
Infections
TBI with
TS
(n16
patients) 94(82-100) 67(23-91) 9 4 3 2
TBI
Without
TS
(n43
patients) 97(92-100) 53(38-68) 126 68 37 21
P value NS NS <.01 <.01 <.01 <.01
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CD4CD25 REGULATORY T CELLS ENHANCE IMMUNE RECONSTI-
TUTION FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANS-
PLANTATION BY PROTECTING THYMIC AND LYMPHOID COMPART-
MENTS FROM GRAFT-VERSUS-HOST DISEASE DAMAGE WITHOUT
IMPACTING T CELL REPERTOIRE DEVELOPMENT
Nguyen, V.H.1, Chang, D.1, Shashidhar, S.1, Bachmann, M.1,
Contag, C.H.1, Brown, J.M.Y.1, Negrin, R.S.1 1Stanford University
School of Medicine, Stanford, CA.
We previously showed that Treg improved the quantitative
and functional lymphoid reconstitution in a murine model of
bone marrow transplantation. We hypothesize that Treg pre-
vent thymic and lymphoid damage from graft-versus-host dis-
ease (GvHD), leading to enhanced lymphoid reconstitution.
Lethally-irradiated adult thymectomized Balb/c (H2d) recipi-
ents received FVB (H2q) T cell depleted bone marrow (TCD-
BM) cells and CD4/CD8 cells (Tcon), the latter to induce
GvHD, with or without donor Treg. At day 30, when all groups
had reached full donor chimerism, transplant recipients were
challenged with murine CMV (5105 pfu/mouse). Day 90 sur-
vival for thymectomized groups with TCD-BM alone, with
Tcon, or with TconTreg was 78%, 0%, and 45%, respec-
tively, compared to 100%, 0%, and 86% survival in their re-
spective euthymic infected counterparts (p0.05 for thymecto-
mized vs euthymic Treg groups). Elispot showed CMV speciﬁc
donor responses in infected groups. Viral titers in the liver and
kidney 2 weeks after infection was lower in Treg recipients
compared to animals that received Tcon alone. Thymectomized
animals had higher viral titers compared to euthymic controls.
Uninfected thymectomized controls in the respective groups
separate the effect of CMV infection from GvHD on survival.
Treg recipients, infected or uninfected, had no clinical GvHD
compared to animals that received Tcon alone. In euthymic
recipients, gross and histologic examination conﬁrmed the gen-
eral preservation of thymic integrity and architecture in Treg
recipients compared with smaller involuted thymuses partially
replaced by adipose tissue in animals that received Tcon alone.
V-beta TCR screening with FACS showed a polyclonal TCR
repertoire in animals with or without Treg. Spectratyping 30
days post-transplantation showed that Treg had no signiﬁcant
impact on the TCR repertoire diversity in animals which re-
ceived Tcon. Survival of a subset of infected thymectomized
animals that received Treg lead to the evaluation of the impact
of Treg on secondary lymphoid organs following HCT. Animals
without Treg had signiﬁcant splenic and lymph node ﬁbrosis
and hypoplasia with a reduction in T cell numbers due to
GvHD. Our ﬁndings indicate that Treg indirectly enhance
immune reconstitution by protecting the thymic and secondary
lymphoid compartments from GvHD damage, allowing the
generation and peripheral expansion of lymphoid cells without
impacting the diversity of T cell repertoire.
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TRANSPLANT CONDITIONS DETERMINE THE CONTRIBUTION OF HOMEO-
STATICALLY EXPANDED DONOR CD8 CELLS TO HOST LYMPHOID RECON-
STITUTION FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION
Roskos, M.1, Levy, R.B.1 1University of Miami, Miami, FL.
Patients undergoing hematopoietic cell transplantation (HCT) typ-
ically experience a period of immune deﬁciency commensurate with
levels of pre-transplant conditioning. Accordingly, developing ap-
proaches to facilitate the reconstitution of the host T cell compart-
ment and restore host immune function post-HCT is an important
clinical challenge. The capacity of T cells to expand under conditions
of lymphopenia is well recognized. To determine the contribution of
homeostatically expanded donor memory CD8 cells (TM) on the
reconstitution of the host CD8 compartment post-HCT, a homoge-
neous TCR-transgenic (tg) TM population was monitored following
transplantation with T cell-depleted C57BL/6 bone marrow into
9.0Gy-conditioned syngeneic recipients. Homeostatic expansion was
assessed by CD8/V5/V2 numbers in recipient spleens begin-
ning 3 days post-HCT. Infused TM expanded for 2 wks then reached
a steady-state splenic number (1.5x1) that was maintained 7
months post-transplant. Similar kinetics and expansion were observed
with a non-tg TM population. To determine how transplant param-
eters affect OT.I homeostatic expansion, reduced intensity condition-
ing, delayed infusion, and varying TM doses were examined. OT.I
TM transplanted after 4.5Gy TBI v 9.0Gy, underwent a shorter
period of expansion (1 v 2 wks) and resulted in lower overall homeo-
static cell numbers (3x2). OT.I TM infused into 9.0Gy-condtioned
recipients a week post-transplant displayed similar kinetics and
reached the same homeostatic number as OT.I cells infused at the
time of transplant. However, when the infusion was delayed for 3 wks,
there was marked reduction in expansion and lower homeostatic
numbers (6x2). Transplantation of 0.1106 OT.I TM v 1.5106
TM, after 9.0Gy, TBI resulted in a shorter period of expansion (1 v 2
wks) and lower set-point (4x2). Interestingly, transplantation of
10106 TM resulted in a rapid expansion the ﬁrst week and steep
contraction the second week followed by a rebound expansion and
contraction. Notably, the ultimate set-point was greater than that
achieved with 1.5106 TM (1.5x1). In total, these results demon-
strate the period of expansion and ultimate homeostataic numbers
depend on the level of conditioning, timing of infusion, and number
of TM transplanted. We conclude these parameters are important
when engineering new strategies designed to enhance immune func-
tion post-transplant, including both immediate anti-tumor immunity
and long-term anti-viral protection.
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HAPLOTYPE MISMATCHED MYELOABLATIVE STEM CELL TRANSPLAN-
TATION: PHASE I CLINICAL TRIAL OF DONOR LYMPHOCYTE INFUSION
DEPLETED OF ALLOREACTIVE T CELLS TO LIMIT INFECTIONS AND
MALIGNANT RELAPSE WITHOUT CAUSING GVHD
Roy, D.C.1, Cohen, S.1, Busque, L.1, Fish, D.1, Kiss, T.1, Lachance, S.1,
Sauvageau, G.1, Caudrelier, P.2, Roy, J.1 1Hopital Maisonneuve-Rose-
mont, Montreal, QC, Canada; 2Celmed BioSciences, Montreal, QC,
Canada.
Patients with very high risk hematologic malignancies who cannot
ﬁnd an HLA-matched related or unrelated donor can beneﬁt from
haplo-mismatched transplantation. The latter is, however, compli-
cated by frequent and severe infectious complications and disease
relapse due to delayed immune reconstitution. We have previously
reported that photodynamic therapy (PDT) could selectively deplete
donor alloreactive populations while preserving lymphocytes for im-
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